366 related articles for article (PubMed ID: 8844209)
41. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
[TBL] [Abstract][Full Text] [Related]
42. Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis.
Drory VE; Birnbaum M; Peleg L; Goldman B; Korczyn AD
Muscle Nerve; 2003 Jul; 28(1):109-12. PubMed ID: 12811781
[TBL] [Abstract][Full Text] [Related]
43. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
44. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews.
Peleg L; Karpati M; Gazit E; Raas-Rothschild A; Goldman B
Biochem Med Metab Biol; 1994 Jun; 52(1):22-6. PubMed ID: 7917464
[TBL] [Abstract][Full Text] [Related]
45. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
Kaplan F
Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
[TBL] [Abstract][Full Text] [Related]
46. Simultaneous preimplantation genetic diagnosis for Tay-Sachs and Gaucher disease.
Altarescu G; Brooks B; Margalioth E; Eldar Geva T; Levy-Lahad E; Renbaum P
Reprod Biomed Online; 2007 Jul; 15(1):83-8. PubMed ID: 17623543
[TBL] [Abstract][Full Text] [Related]
47. Carrier testing for autosomal-recessive disorders.
Vallance H; Ford J
Crit Rev Clin Lab Sci; 2003 Aug; 40(4):473-97. PubMed ID: 14582604
[TBL] [Abstract][Full Text] [Related]
48. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
Broide E; Zeigler M; Eckstein J; Bach G
Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
[TBL] [Abstract][Full Text] [Related]
49. Eight novel mutations in the HEXA gene.
McGinniss MJ; Brown DH; Fulwiler A; Marten M; Lim-Steele JS; Kaback MM
Genet Med; 2002; 4(3):158-61. PubMed ID: 12180151
[TBL] [Abstract][Full Text] [Related]
50. PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.
Brillante R; Yang V; Proos A; Burnett L
Clin Chem; 1995 Feb; 41(2):321-2. PubMed ID: 7874790
[No Abstract] [Full Text] [Related]
51. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
[TBL] [Abstract][Full Text] [Related]
52. Population-based carrier screening and prenatal diagnosis.
Strom CM
MLO Med Lab Obs; 2004 Aug; 36(8):12-7; quiz 20-1. PubMed ID: 15366363
[No Abstract] [Full Text] [Related]
53. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.
Paw BH; Neufeld EF
J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434
[TBL] [Abstract][Full Text] [Related]
54. The molecular basis of Tay-Sachs disease: mutation identification and diagnosis.
Mahuran DJ; Triggs-Raine BL; Feigenbaum AJ; Gravel RA
Clin Biochem; 1990 Oct; 23(5):409-15. PubMed ID: 2147596
[TBL] [Abstract][Full Text] [Related]
55. Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.
Cecchi AC; Vengoechea ES; Kaseniit KE; Hardy MW; Kiger LA; Mehta N; Haque IS; Moyer K; Page PZ; Muzzey D; Grinzaid KA
Mol Genet Genomic Med; 2019 Aug; 7(8):e836. PubMed ID: 31293106
[TBL] [Abstract][Full Text] [Related]
56. Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.
Mehta N; Lazarin GA; Spiegel E; Berentsen K; Brennan K; Giordano J; Haque IS; Wapner R
Genet Test Mol Biomarkers; 2016 Sep; 20(9):504-9. PubMed ID: 27362553
[TBL] [Abstract][Full Text] [Related]
57. Homozygosity for the common Ashkenazi jewish Tay-Sachs +1 IVS-12 splice-junction mutation: first report.
Strasberg P; Warren I; Skomorowski MA; Feigenbaum A
Hum Mutat; 1997; 10(1):82-3. PubMed ID: 9222766
[No Abstract] [Full Text] [Related]
58. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
59. Multiple abnormal beta-hexosaminidase alpha chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease.
Ohno K; Suzuki K
J Biol Chem; 1988 Dec; 263(34):18563-7. PubMed ID: 2973464
[TBL] [Abstract][Full Text] [Related]
60. Changes of serum hexosaminidase for the presumptive diagnosis of type I Gaucher disease in Tay-Sachs carrier screening.
Nakagawa S; Kumin S; Sachs G; Nitowsky HM
Am J Med Genet; 1983 Mar; 14(3):525-32. PubMed ID: 6859103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
